| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT04938817 Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-27 | NCT06843447 A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
Trial sites expanded: 17 -> 20 locations |
| 2026-05-23 | NCT06161025 A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade… |
Trial sites expanded: 129 -> 146 locations |
| 2026-05-14 | NCT06843447 A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
Enrollment increased: 280 -> 460 participants |
| 2026-05-14 | NCT06843447 A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) |
Trial arms changed: 7 -> 10 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2/3 | |||
| NCT06161025 | A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade… | Solid Cancer | Recruiting |
| Phase 2 | |||
| NCT06780085 | A Study of Investigational Agents in Participants With Previously Treated Stage IV… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT06780098 | Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated… | Lung Neoplasm | Recruiting |
| NCT06864169 | A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers… | Gastrointestinal Cancer | Active, Not Recruiting |
| NCT06660654 | A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors… | Advanced Solid Tumor | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06843447 | A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) | Ovarian Cancer Recurrent | Recruiting |
| NCT04938817 | Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With… | Small Cell Lung Carcinoma | Active, Not Recruiting |